Pharmaceutical Applications of Shellac: Moisture-Protective and Taste-Masking Coatings and Extended-Release Matrix Tablets

@article{Pearnchob2003PharmaceuticalAO,
  title={Pharmaceutical Applications of Shellac: Moisture-Protective and Taste-Masking Coatings and Extended-Release Matrix Tablets},
  author={N. Pearnchob and J. Siepmann and R. Bodmeier},
  journal={Drug Development and Industrial Pharmacy},
  year={2003},
  volume={29},
  pages={925 - 938}
}
Abstract Shellac is a natural polymer, which is used as enteric coating material in pharmaceutical applications. The major objective of the present study was to investigate the potential of shellac for other purposes, namely to provide moisture-protective and taste-masking coatings as well as extended-release matrix tablets. The efficiency of shellac to achieve moisture protection and taste masking was compared with that of hydroxypropyl methylcellulose (HPMC), which is most frequently used for… Expand
Effect of coating excipients on chemical stability of active coated tablets
TLDR
Higher stability of triacetin systems over PEG systems was attributed to lower solubility and mobility of peliglitazar in HPMC compared with the PVA-based coating, while for the same plasticizer/detackifier, higher stability of H PMC over PVA, based on the overall stability for the film-forming polymer-plasticizer/ Detackifier combination. Expand
Protection of moisture-sensitive drugs with aqueous polymer coatings: importance of coating and curing conditions.
TLDR
Curing at elevated temperature after coating did not improve the moisture-protective ability of the polymeric films, but reduced the water content of the tablets, and drug stability was significantly improved with tablets coated with poly(vinyl alcohol) and poly(methacrylate-methylmethACrylates). Expand
Modification of shellac coating using Jeffamine® for enhanced mechanical properties and stability
Abstract Shellac is a unique natural resin derived from the secretion of insects. It is widely used as a preservative coating or a confectionary glaze in the food industry and as an enteric coatingExpand
An Update of Moisture Barrier Coating for Drug Delivery
TLDR
Different strategies have been designed and developed to effectively decrease water vapor permeability and improve the moisture barrier function of the film and could potentially replace the current solvent and aqueous coatings. Expand
Modulation of drug release kinetics of shellac-based matrix tablets by in-situ polymerization through annealing process.
TLDR
A new oral-controlled release matrix tablet based on shellac polymer was designed and developed, using metronidazole (MZ) as a model drug, and modulation of MZ release kinetics from shellac-based matrix tablets could be accomplished by varying the amount of shellac or the annealing temperature. Expand
Investigation of drug release from pellets coated with different shellac types
TLDR
The Thai shellac stands out providing both gastric resistance at low CLs and fast drug release at high pH 6.8, and the intrinsic dissolution rate turned out to be a good indicator for the drug release behavior. Expand
Taste masking of naproxen sodium granules by fluid-bed coating
TLDR
An optimum ratio between naproxen sodium granules and Eudragit® E was found to be 1:1.576, where less naproxin sodium was released than the threshold bitter value and an appropriate taste masking for more than 5 min was guaranteed. Expand
Influence of the inlet air temperature in a fluid bed coating process on drug release from shellac-coated pellets
TLDR
Pellets coated at lower temperatures showed distinct cracks in the coating film resulting in a loss of the barrier function during dissolution testing, and these cracks were nonreversible by additional curing. Expand
Quality Properties of Enteric-Coated Soft Capsule Using PEG as a Plasticizer
We investigated the applicability of polyethylene glycol (PEG) as a plasticizer in enteric-coated soft capsules based on determination of quality characteristics according to molecular weight andExpand
Excipient Selection in Oral Solid Dosage Formulations Containing Moisture Sensitive Drugs
Moisture sensitivity of active pharmaceutical ingredients (APIs) presents a formidable challenge in the formulation of oral dosage forms. The interaction of moisture with APIs is crucial to anExpand
...
1
2
3
4
5
...

References

SHOWING 1-10 OF 35 REFERENCES
Polymers with pH-Dependent Solubility: Possibility of Use in the Formulation of Gastroresistant and Controlled-Release Matrix Tablets
TLDR
Polymers usually utilized for gastroresistant film coating of tablets or pellets such as cellulose acetate phthalate (CAP) and Eudragit L and S were used in the preparation of drug/polymer matrix tablets to verify if the tablets possessed gastroresistant or controlled-release characteristics. Expand
Taste masked pharmaceutical particles
PURPOSE: Taste masked particles containing a polymeric film as a mixture of an enteric polymer and an insoluble film-forming polymer are provided. Therefore, the masked particles can be used for theExpand
Use of hydroxypropyl methylcellulose acetate succinate in an enteric polymer matrix to design controlled-release tablets of amoxicillin trihydrate.
TLDR
A controlled-release table of amoxicillin trihydrate developed by use of a matrix formulation based on the enteric polymer hydroxypropyl methylcellulose acetate succinate showed a promising sustained-release effect in vitro when a variable-pH-shift dissolution procedure was used, but single-dose studies showed that the tablets had a relative bioavailability of only 64.4%. Expand
The Influence of Excipients on the Stability of the Moisture Sensitive Drugs Aspirin and Niacinamide: Comparison of Tablets Containing Lactose Monohydrate with Tablets Containing Anhydrous Lactose
  • J. Du, S. Hoag
  • Chemistry, Medicine
  • Pharmaceutical development and technology
  • 2001
The purpose of this study is to test the hypothesis that in tablet formulations, moisture-sensitive drugs formulated with lactose monohydrate have the same stability as formulations containingExpand
In vitro/in vivo evaluation of two series of TA-5707F controlled release matrix tablets prepared with hydroxypropyl methyl cellulose derivatives with entero-soluble or gel-formation properties.
TLDR
Two series of matrix tablets for the newly developed anti-histaminergic drug, TA-5707F, were prepared, and the H-2 and H-3 tablets were administered to humans; however, the plasma concentration profiles did not show sufficient duration time for either tablet. Expand
Comparative evaluation of ammoniated aqueous and organic-solvent-based cellulose ester enteric coating systems : a study on free films
Abstract The permeability and mechanical properties of ammoniated aqueous and organic-solvent-based enteric films were evaluated with free films and with the films applied to tablets. The entericExpand
The In Vitro and In Vivo Performance of Aqueous Bases Enteric Coats of Neutralised Hydroxypropyl Methyl Cellulose Phthalate
AbstractPrednisolone tablets, enteric coated with neutralised hydroxypropyl methylcellulose phthalate (HPMCP) were compared with Deltacortril tablets (Pfizer) by compendial in vitro testing and aExpand
Bimodal drug release achieved with multi-layer matrix tablets: transport mechanisms and device design.
The aim of this study was to develop new multi-layer matrix tablets to achieve bimodal drug release profiles (fast release/slow release/fast release). Hydroxypropyl methylcellulose acetate succinateExpand
Evaluation of biodegradable poly(lactide) pellets prepared by direct compression.
Biodegradable pellets intended for either parenteral or oral use were successfully prepared from low molecular weight poly(DL-lactide) (low MW PLA, MW' = 2000) or a relatively high molecular weightExpand
Preparation and evaluation of shellac pseudolatex as an aqueous enteric coating system for pellets
Abstract A soap-free shellac pseudolatex was prepared using a changing solvent technique. In the present study, theophylline sustained release pellets were used as model cores for the shellacExpand
...
1
2
3
4
...